Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H13NO2 |
Molecular Weight | 167.205 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC[C@H](O)C1=CC(O)=CC=C1
InChI
InChIKey=SONNWYBIRXJNDC-VIFPVBQESA-N
InChI=1S/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1
Molecular Formula | C9H13NO2 |
Molecular Weight | 167.205 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:06:37 UTC 2023
by
admin
on
Fri Dec 15 15:06:37 UTC 2023
|
Record UNII |
1WS297W6MV
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
773
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-VATC |
QR01BA03
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-VATC |
QS01FB01
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-VATC |
QR01AA04
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-VATC |
QC01CA06
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-ATC |
R01BA03
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-ATC |
R01AB01
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-ATC |
R01BA53
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-VATC |
QS01GA55
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-ATC |
C01CA06
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-ATC |
S01BB01
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-VATC |
QS01GA05
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-VATC |
QR01AB01
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-ATC |
S01FB51
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-ATC |
S01FB01
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
FDA ORPHAN DRUG |
147201
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-VATC |
QR01BA53
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
NCI_THESAURUS |
C29709
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-ATC |
S01GA55
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
NDF-RT |
N0000186105
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-ATC |
R01AA04
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
WHO-ATC |
S01GA05
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
||
|
FDA ORPHAN DRUG |
359011
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C62067
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
59-42-7
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
8163
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
D010656
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
CHEMBL1215
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
325517
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
ALTERNATIVE | |||
|
1WS297W6MV
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
8093
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
DTXSID9023465
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
485
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
SUB09788MIG
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
3383
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
DB00388
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
Phenylephrine
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
6041
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
200-424-8
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
2146
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
N0000009917
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | Adrenergic alpha1-Agonists [MoA] | ||
|
1WS297W6MV
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
m8668
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000088260
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
PHENYLEPHRINE
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY | |||
|
4174
Created by
admin on Fri Dec 15 15:06:37 UTC 2023 , Edited by admin on Fri Dec 15 15:06:37 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> AGONIST |
Binding Assay
IC50
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> AGONIST | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
RACEMATE -> ENANTIOMER |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Vdss | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||